Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 6451 to 6500 of 8235 results

  1. Postural hypotension in adults: midodrine (ESUOM5)

    This evidence summary has been updated and replaced by NICE evidence summary: new medicines 61.

  2. Pulmonary hypertension in neonates: sildenafil (ESUOM51)

    This evidence summary has been withdrawn following updated information in the summary of product characteristics on the off-label use of sildenafil (Revatio) in neonates with persistent pulmonary hypertension of the newborn.

  3. Management of aggression, agitation and behavioural disturbances in dementia: carbamazepine (ESUOM40)

    This evidence summary has been updated and replaced by NICE guideline NG97.

  4. Rapid tranquillisation in mental health settings: promethazine hydrochloride (ESUOM28)

    This evidence summary has been updated and replaced by NICE guideline NG10.

  5. Transient ischaemic attack: clopidogrel (ESUOM23)

    This evidence summary has been withdrawn and NICE accredited guidance is available from the Royal College of Physicians.

  6. Non-cystic fibrosis bronchiectasis: colistimethate sodium (ESUOM25)

    This evidence summary has been updated and replaced by NICE guideline NG117.

  7. Interstitial cystitis: dimethyl sulfoxide bladder instillation (ESUOM26)

    This evidence summary has been withdrawn because the product has been discontinued in the UK.

  8. Chronic pain: oral ketamine (ESUOM27)

    This evidence summary has been updated and replaced by NICE guideline NG193.

  9. Ataluren for treating Duchenne muscular dystrophy with a nonsense mutation in the dystrophin gene (HST3)

    This guidance has been updated and replaced by NICE highly specialised technologies guidance 22.

  10. Elosulfase alfa for treating mucopolysaccharidosis type IVa (HST2)

    This guidance has been updated and replaced by NICE’s highly specialised technologies guidance on elosulfase alfa for treating mucopolysaccharidosis type 4A (HST19).

  11. Asfotase alfa for treating paediatric-onset hypophosphatasia (HST6)

    This guidance has been updated and replaced by NICE highly specialised technologies guidance 23.

  12. Attention deficit hyperactivity disorder in children and young people: clonidine (ESUOM8)

    This evidence summary has been updated and replaced by NICE guideline NG87.

  13. Fatigue in multiple sclerosis: modafinil (ESUOM9)

    This advice has been updated and replaced by NICE guideline NG220.

  14. Diagnosing prostate cancer: PROGENSA PCA3 assay and Prostate Health Index (DG17)

    This guideline has been updated and replaced by NICE guideline NG131.

  15. Biodegradable spacer insertion to reduce rectal toxicity during radiotherapy for prostate cancer (IPG590)

    This guidance has been updated and replaced by NICE interventional procedures guidance 752.

  16. Laparoscopic insertion of a magnetic titanium ring for gastro-oesophageal reflux disease (IPG585)

    This guidance has been updated and replaced by NICE interventional procedures guidance 749.

  17. Transurethral water jet ablation for lower urinary tract symptoms caused by benign prostatic hyperplasia (IPG629)

    This guidance has been updated and replaced by NICE interventional procedures guidance 770.

  18. Arteriovenous crossing sheathotomy for branch retinal vein occlusion (IPG72)

    This guidance has been updated and replaced by NICE interventional procedure guidance 334.

  19. Percutaneous intradiscal electrothermal therapy for lower back pain (IPG81)

    This guidance has been updated and replaced by NICE interventional procedure guidance 319.

  20. High-flow interposition extracranial to intracranial bypass (IPG73)

    This guidance has been updated and replaced by NICE interventional procedure guidance 348.

  21. Endoscopic division of epidural adhesions (IPG88)

    This guidance has been updated and replaced by NICE interventional procedure guidance 333.

  22. Photodynamic therapy for high-grade dysplasia in Barrett's oesophagus (IPG82)

    This guidance has been updated and replaced by NICE interventional procedure guidance 344.

  23. Coblation tonsillectomy (IPG9)

    This guidance has been updated and replaced by NICE interventional procedure guidance 150.

  24. Percutaneous radiofrequency ablation of renal cancer (IPG91)

    This guidance has been updated and replaced by NICE interventional procedure guidance 353.

  25. Radiofrequency ablation for the treatment of colorectal metastases in the liver (IPG92)

    This guidance has been updated and replaced by NICE interventional procedure guidance 327.

  26. Selective internal radiation therapy for colorectal metastases in the liver (IPG93)

    This guidance has been updated and replaced by NICE interventional procedure guidance 401.

  27. Uterine artery embolisation for fibroids (IPG94)

    This guidance has been updated and replaced by NICE interventional procedure guidance 367.

  28. Sacral nerve stimulation for faecal incontinence (IPG5)

    This guidance has been updated and replaced by NICE interventional procedure guidance 99.

  29. Hysteroscopic morcellation of uterine leiomyomas (fibroids) (IPG522)

    This guidance has been updated and replaced by NICE interventional procedures guidance 704.

  30. Transcutaneous neuromuscular electrical stimulation for oropharyngeal dysphagia (IPG490)

    This guidance has been updated and replaced by NICE interventional procedures guidance 634.

  31. Transapical transcatheter mitral valve-in-valve implantation for a failed surgically implanted mitral valve bioprosthesis (IPG541)

    This guidance has been updated and replaced by NICE interventional procedures guidance 706.

  32. Cyanoacrylate glue occlusion for varicose veins (IPG526)

    This guidance has been updated and replaced by NICE interventional procedures guidance 670.

  33. Transcutaneous electrical stimulation of the supraorbital nerve for treating and preventing migraine (IPG559)

    This guidance has been updated and replaced by NICE interventional procedures guidance 740.

  34. Extracorporeal carbon dioxide removal for acute respiratory failure (IPG564)

    This guidance has been updated and replaced by NICE interventional procedure guidance 776.

  35. Balloon thermal endometrial ablation (using data from Cavaterm and Gynecare as specified by SERNIP) (IPG6)

    This guidance has been updated and replaced by NICE guideline CG44.

  36. Biodegradable subacromial spacer insertion for rotator cuff tears (IPG558)

    This guidance has been updated and replaced by NICE interventional procedures guidance IPG775.

  37. Liposuction for chronic lymphoedema (IPG588)

    This guidance has been updated and replaced by NICE interventional procedures guidance 723.

  38. Irreversible electroporation for treating prostate cancer (IPG572)

    This guidance has been updated and replaced by NICE interventional procedures guidance 768.

  39. Microwave endometrial ablation (IPG7)

    This guidance has been withdrawn as the use of this procedure is now covered in the NICE guideline on heavy menstrual bleeding (CG44). NICE has no plans to carry out further assessment of this procedure under the Interventional Procedures Programme.

  40. Endovascular stent insertion for intracranial atherosclerotic disease (IPG233)

    This guidance has been updated and replaced by NICE interventional procedure guidance 429.

  41. Percutaneous pulmonary valve implantation for right ventricular outflow tract dysfunction (IPG237)

    This guidance has been updated and replaced by NICE Interventional procedure guidance 436.

  42. Laparoscopic radical hysterectomy for early stage cervical cancer (IPG24)

    This guidance has been updated and replaced by NICE interventional procedure guidance 338.

  43. Circumferential epithelial radiofrequency ablation for Barrett's oesophagus (IPG244)

    This guidance has been updated and replaced by NICE interventional procedure guidance 344.

  44. Arteriovenous extracorporeal membrane carbon dioxide removal (IPG250)

    This guidance has been updated and replaced by NICE interventional procedure guidance 428.

  45. Suburethral synthetic sling insertion for stress urinary incontinence in men (IPG256)

    This guidance has been withdrawn as the use of this procedure is now covered in NICE guideline CG97. NICE has no plans to carry out further assessment of this procedure under the Interventional procedures programme.

  46. Endoscopic saphenous vein harvest for coronary artery bypass grafting (IPG248)

    This guidance has been updated and replaced by NICE interventional procedure guidance 343.

  47. Liposuction for chronic lymphoedema (IPG251)

    This guidance has been updated and replaced by NICE interventional procedures guidance 588

  48. Laparoscopic cystectomy (of the urinary bladder) (IPG26)

    This guidance has been updated and replaced by NICE interventional procedure guidance 287.

  49. Stent insertion for bleeding oesophageal varices (IPG265)

    This guidance has been updated and replaced by NICE interventional procedure guidance 392.